Pardes Biosciences
Biotechnology ResearchCalifornia, United States51-200 Employees
Pardes Biosciences is a clinical-stage biotechnology company based in Carlsbad, California, focused on developing oral antiviral candidates to address COVID-19 and related pandemic-sized challenges. The organization emphasizes patient-friendly approaches to drug access, aiming to streamline the patient journey through innovations in telehealth and at-home diagnostics while pursuing reversible-covalent chemistry as a basis for discovery and development. Its work centers on advancing an oral antiviral portfolio, with an emphasis on making treatment more accessible and timely for patients. The company operates within the biotechnology research sector, pursuing therapies that could serve patients seeking convenient, at-home or remote-access options for treatment. As a mid-sized enterprise, Pardes has seen leadership changes and strategic appointments in its recent history, and its recent activity includes business developments and governance shifts. The firm is headquartered in California and presents itself as addressing urgent, global health needs through its pipeline and clinical-stage programs.
1-888-653-2347 
support@leadiq.com 
